These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30117265)

  • 41. Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study.
    Moavero R; Voci A; La Briola F; Matricardi S; Toldo I; Mancardi MM; Negrin S; Messana T; Mazzone L; Valeriani M; Curatolo P; Bruni O
    Sleep Med; 2022 Jan; 89():65-70. PubMed ID: 34915263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results.
    Ruiz-Falcó Rojas ML; Feucht M; Macaya A; Wilken B; Hahn A; Maamari R; Hirschberg Y; Ridolfi A; Kingswood JC
    Front Pharmacol; 2022; 13():802334. PubMed ID: 35462939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complex.
    Chung TK; Lynch ER; Fiser CJ; Nelson DA; Agricola K; Tudor C; Franz DN; Krueger DA
    Ann Clin Psychiatry; 2011 Nov; 23(4):263-9. PubMed ID: 22073383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship of neuroimaging findings and neuropsychiatric comorbidities in children with tuberous sclerosis complex.
    Huang CH; Peng SS; Weng WC; Su YN; Lee WT;
    J Formos Med Assoc; 2015 Sep; 114(9):849-54. PubMed ID: 24698169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tuberous sclerosis complex: Concerns and needs of patients and parents from the transitional period to adulthood.
    Both P; Ten Holt L; Mous S; Patist J; Rietman A; Dieleman G; Ten Hoopen L; Vergeer M; de Wit MC; Bindels-de Heus K; Moll H; van Eeghen A
    Epilepsy Behav; 2018 Jun; 83():13-21. PubMed ID: 29631156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex.
    D'Agati E; Moavero R; Cerminara C; Curatolo P
    J Child Neurol; 2009 Oct; 24(10):1282-7. PubMed ID: 19805824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families.
    de Vries PJ; Hunt A; Bolton PF
    Eur Child Adolesc Psychiatry; 2007 Feb; 16(1):16-24. PubMed ID: 17268883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
    Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
    Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis.
    de Vries P; Humphrey A; McCartney D; Prather P; Bolton P; Hunt A;
    Eur Child Adolesc Psychiatry; 2005 Jul; 14(4):183-90. PubMed ID: 15981129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An Updated Review of Tuberous Sclerosis Complex-Associated Autism Spectrum Disorder.
    Samanta D
    Pediatr Neurol; 2020 Aug; 109():4-11. PubMed ID: 32563542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropsychiatric problems in tuberous sclerosis complex.
    Asato MR; Hardan AY
    J Child Neurol; 2004 Apr; 19(4):241-9. PubMed ID: 15163088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation.
    Hwang SK; Lee JH; Yang JE; Lim CS; Lee JA; Lee YS; Lee K; Kaang BK
    Mol Brain; 2016 May; 9(1):56. PubMed ID: 27216612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genotype/phenotype in tuberous sclerosis complex: associations with clinical and radiologic manifestations.
    Kothare SV; Singh K; Hochman T; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
    Epilepsia; 2014 Jul; 55(7):1020-4. PubMed ID: 24754401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem).
    Heunis TM; Bissell S; Byars AW; Capal JK; Chambers N; Cukier S; Davis PE; De Waele L; Flinn J; Gardner-Lubbe S; Gipson T; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; Vanclooster S; van Eeghen AM; Waltereit R; Jansen AC; de Vries PJ
    Front Psychiatry; 2022; 13():834628. PubMed ID: 35295772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex.
    Muzykewicz DA; Newberry P; Danforth N; Halpern EF; Thiele EA
    Epilepsy Behav; 2007 Dec; 11(4):506-13. PubMed ID: 17936687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autism spectrum disorder in tuberous sclerosis complex: searching for risk markers.
    Vignoli A; La Briola F; Peron A; Turner K; Vannicola C; Saccani M; Magnaghi E; Scornavacca GF; Canevini MP
    Orphanet J Rare Dis; 2015 Dec; 10():154. PubMed ID: 26631248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early predictors of clinical and mental outcome in tuberous sclerosis complex: A prospective study.
    Benova B; Petrak B; Kyncl M; Jezdik P; Maulisova A; Jahodova A; Komarek V; Krsek P
    Eur J Paediatr Neurol; 2018 Jul; 22(4):632-641. PubMed ID: 29636221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Manifestations of Tuberous Sclerosis Complex: The Experience of a Provincial Clinic.
    Wilbur C; Sanguansermsri C; Chable H; Anghelina M; Peinhof S; Anderson K; Steinbok P; Singhal A; Datta A; Connolly MB
    Can J Neurol Sci; 2017 Jan; 44(1):35-43. PubMed ID: 28004629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autism and tuberous sclerosis.
    Wiznitzer M
    J Child Neurol; 2004 Sep; 19(9):675-9. PubMed ID: 15563013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attention deficits in tuberous sclerosis complex (TSC): rethinking the pathways to the endstate.
    de Vries PJ; Watson P
    J Intellect Disabil Res; 2008 Apr; 52(Pt 4):348-57. PubMed ID: 18179508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.